Also known as: BCX-1812; RWJ-270201; Rapiacta (brand); Peramiflu (brand)
Peramivir is a cyclopentane-based neuraminidase inhibitor used as an antiviral agent against influenza A and B infections. Mediocon Inc manufactures this high-purity API at its GMP-certified facility in Aurangabad, Maharashtra, India. Peramivir is unique among neuraminidase inhibitors as it is administered intravenously, making it suitable for hospitalized patients and those unable to take oral or inhaled antivirals. It received FDA approval for treatment of acute uncomplicated influenza.
| Parameter | Specification |
|---|---|
| CAS Number | 229614-55-5 |
| Molecular Formula | C₁₅H₂₈N₄O₄ |
| Molecular Weight | 328.41 g/mol |
| Grade | IP / BP / EP / USP |
| Category | Antiviral / Neuraminidase Inhibitor |
| Assay | NLT 98.0% |
| Loss on Drying | NMT 0.5% |
| Heavy Metals | NMT 20 ppm |
| Residue on Ignition | NMT 0.1% |
| Microbial Limits | Complies with pharmacopoeia |
| Identification | IR, HPLC Compliant |
| Batch No | PMV/24032026 |
| Mfg Date | MAR 2026 |
| Exp Date | FEB 2031 |
| Packing | 25 kg HDPE drums / as per requirement |
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Peramivir — CAS 229614-55-5 (CAS 229614-55-5) and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our Peramivir — CAS 229614-55-5 is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing — identity (IR/HPLC), assay, related substances, residual solvents (ICH Q3C), heavy metals, and microbial limits — before release with a Certificate of Analysis.
Export Markets
Quality & Compliance